4.2 Editorial Material

Montelukast's ability to fight COVID-19 infection

Journal

JOURNAL OF ASTHMA
Volume 58, Issue 10, Pages 1348-1349

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/02770903.2020.1786112

Keywords

Prevention; geriatric

Ask authors/readers for more resources

Montelukast can be effective in treating SARS-CoV-2 infection.
Montelukast can be effective in the treatment of SARS-CoV-2 infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Allergy

Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model

Cristoforo Incorvaia, Mona Al-Ahmad, Ignacio J. Ansotegui, Stefania Arasi, Claus Bachert, Catherine Bos, Jean Bousquet, Andrzej Bozek, Davide Caimmi, Moises A. Calderon, Thomas Casale, Adnan Custovic, Frederic De Blay, Pascal Demoly, Philippe Devillier, Alain Didier, Alessandro Fiocchi, Adam T. Fox, Philippe Gevaert, Maximiliano Gomez, Enrico Heffler, Natalia Ilina, Carla Irani, Marek Jutel, Efstrathios Karagiannis, Ludger Klimek, Piotr Kuna, Robin O'Hehir, Oxana Kurbacheva, Paolo M. Matricardi, Mario Morais-Almeida, Ralph Mosges, Natalija Novak, Yoshitaka Okamoto, Petr Panzner, Nikolaos G. Papadopoulos, Hae-Sim Park, Giovanni Passalacqua, Ruby Pawankar, Oliver Pfaar, Peter Schmid-Grendelmeier, Silvia Scurati, Miguel Tortajada-Girbes, Carmen Vidal, J. Christian Virchow, Ulrich Wahn, Margitta Worm, Petra Zieglmayer, Giorgio W. Canonica

Summary: The introduction of personalized medicine has revolutionized the approach to treating diseases by focusing on treating the individual patient. Personalized medicine has shown significant improvements in allergy diagnosis by identifying specific allergens and predicting patient responsiveness to therapies, thereby enhancing the effectiveness of allergen immunotherapy.

ALLERGY (2021)

Article Allergy

β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

Gunter Johannes Sturm, Sereina Annik Herzog, Werner Aberer, Teresa Alfaya Arias, Dario Antolin-Amerigo, Patrizia Bonadonna, Elisa Boni, Andrzej Bozek, Marta Chelminska, Barbara Ernst, Nina Frelih, Radoslaw Gawlik, Asli Gelincik, Thomas Hawranek, Wolfram Hoetzenecker, Aranzazu Jimenez Blanco, Karolina Kita, Resat Kendirlinan, Mitja Kosnik, Karin Laipold, Roland Lang, Francesco Marchi, Marina Mauro, Marita Nittner-Marszalska, Iwona Poziomkowska-Gesicka, Valerio Pravettoni, Donatella Preziosi, Oliviero Quercia, Norbert Reider, Marta Rosiek-Biegus, Berta Ruiz-Leon, Christoph Schrautzer, Pilar Serrano, Aytul Sin, Betul Ayse Sin, Johanna Stoevesandt, Axel Trautmann, Martina Vachova, Lisa Arzt-Gradwohl

Summary: The study found that taking beta-blockers or ACE inhibitors does not increase the frequency of systemic adverse events during venom immunotherapy, nor aggravate systemic insect sting reactions. Additionally, these drugs do not impair the effectiveness of venom immunotherapy.

ALLERGY (2021)

Article Biotechnology & Applied Microbiology

Impact of influenza vaccination on the risk of SARS-CoV-2 infection in a middle-aged group of people

Andrzej Bozek, Renata Kozlowska, Beata Galuszka, Alicja Grzanka

Summary: The observational study found that after influenza vaccination, middle-aged individuals had a significantly lower risk of SARS-CoV-2 infection, indicating that the vaccine may partially reduce the risk of infection.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Infectious Diseases

Photodynamic Therapy for the Treatment of Infected Leg Ulcers-A Pilot Study

Magdalena Krupka, Andrzej Bozek, Dorota Bartusik-Aebisher, Grzegorz Cieslar, Aleksandra Kawczyk-Krupka

Summary: The study demonstrated the efficacy of photodynamic therapy for infected chronic leg ulcers, with 40% of patients achieving complete remission, 40% experiencing partial response, and 20% showing no response. It also suggested that PDT can be used as a minimally invasive and effective method for treating leg ulcers.

ANTIBIOTICS-BASEL (2021)

Article Allergy

Allergen immunotherapy against house dust mites in patients with local allergic rhinitis and asthma

Andrzej Bozek, Beata Galuszka, Radoslaw Gawlik, Maciej Misiolek, Wojciech Scierski, Alicja Grzanka, Giorgio Walter Canonica

Summary: For adult patients with local allergic rhinitis and asthma, a 12-month course of sublingual immunotherapy for house dust mite allergies can improve nasal and bronchial symptoms and reduce symptomatic treatment.

JOURNAL OF ASTHMA (2022)

Article Allergy

Allergy to Der p 23 influences the cytokine profile in patients with allergic asthma - a preliminary study

Andrzej Bozek, Jolanta Zalejska Fiolka, Zenon Czuba, Martyna Miodonska, Renata Kozlowska

Summary: This study compared the cytokine profile in patients with allergic asthma and analyzed the impact of Der p 23 allergy. The results showed that patients with Der p 23 allergy had higher levels of Il-1 and Il-5 activity, which could contribute to more effective allergic inflammation.

JOURNAL OF ASTHMA (2022)

Article Allergy

Immunological differences between atopic dermatitis, psoriasis, and their combination in adult patients

Magdalena Krupka-Olek, Andrzej Bozek, Milena Drewienkowska, Krzysztof Dryjka, Agata Medrala

Summary: This study analyzed a group of adult patients with concomitant psoriasis and atopic dermatitis, and compared their cytokine profiles with those of homogeneous psoriasis or atopic dermatitis patients and healthy controls. The results suggest that the role of T helper 17 cells may be more essential than previously thought.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2022)

Article Biotechnology & Applied Microbiology

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis

Andrzej Bozek, Renata Kozlowska, Maciej Misiolek, Wojciech Scierski, Radoslaw Gawlik

Summary: This study investigated the combined therapy of omalizumab and sublingual immunotherapy in patients with house dust mite allergy and local allergic rhinitis (LAR). The results showed significant improvements in symptom scores and medication usage compared to therapy with omalizumab alone or sublingual immunotherapy alone.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Biotechnology & Applied Microbiology

Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients

Marita Nittner-Marszalska, Agnieszka Kopec, Aleksandra Foks-Ciekalska, Aleksandra Lata, Agnieszka Bogacz- Piaseczynska, Marta Rosiek-Biegus, Magdalena Zajac, Andrzej Bozek

Summary: This study aimed to investigate whether immunotherapy with HDM extracts leads to new sensitizations and found that no new sensitizations were observed in patients receiving immunotherapy, while new sensitizations to one HDM molecule were observed in patients who did not receive immunotherapy. Additionally, the study found that sIgE levels against HDM extracts decreased in some patients after 12 months of immunotherapy.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Review Allergy

Clinical outcomes of AIT in the elderly population

Andrzej Bozek

Summary: This review presents current knowledge on the effectiveness and safety of allergen immunotherapy (AIT) in patients over 60 years old with inhalant allergies. Studies have shown the effectiveness of AIT in treating allergic rhinitis in seniors, with evidence from trials using sublingual and injection immunotherapy. Data confirm the high safety of AIT in this age group. Seniors with allergic rhinitis or asthma may benefit from AIT if there are no contraindications, and sustained clinical benefit can be experienced even after completing treatment.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Medicine, General & Internal

The Effect of Biological Treatment on Stress Parameters Determined in Saliva in Patients with Severe Psoriasis

Aleksandra Foks-Ciekalska, Jerzy Jarzab, Ewa Hadas, Elzbieta Swietochowska, Kamila Gumieniak, Wiktor Ciekalski, Andrzej Bozek

Summary: This study aimed to assess the usefulness of potential stress biomarkers in saliva for monitoring the treatment of psoriasis. The results showed that saliva concentrations of sIgA, sAA, and CgA can serve as potential markers for measuring the severity of psoriasis and the associated stress reaction.

MEDICINA-LITHUANIA (2023)

Article Medicine, General & Internal

Acquired Angioedema in Selected Neoplastic Diseases

Magdalena Zajac, Andrzej Bozek, Renata Kozlowska, Alicja Grzanka

Summary: This study aimed to assess the incidence of a subtype of angioedema-C1-INH-AAE (acquired angioedema with C1 inhibitor deficiency). The study found that C1-INH-AAE occurred more often in patients with cancer, especially in the early stages of breast cancer.

MEDICINA-LITHUANIA (2023)

Article Medicine, General & Internal

The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites

Agnieszka Bogacz-Piaseczynska, Andrzej Bozek

Summary: This study investigated the efficacy and safety of allergen immunotherapy (AIT) in adult patients with atopic dermatitis (AD) and monosensitisation to house dust mites (HDMs). The results showed significant improvement in skin symptoms of AD patients after 12 months of AIT treatment, with decreased EASI scores, % BSA, and IsGA index compared to the placebo group. Therefore, HDM-AIT is effective in improving atopic dermatitis in patients with confirmed monovalent mite allergy.

MEDICINA-LITHUANIA (2023)

Article Medicine, General & Internal

The Immunological and Allergen Profiles of Patients with Atopic Dermatitis or Psoriasis

Magdalena Krupka-Olek, Andrzej Bozek, Aleksandra Kawczyk-Krupka

Summary: Inhalation-dependent IgE sensitizations were common in patients with atopic dermatitis (AD) and possible in patients with psoriasis (PS), often without clinical manifestations in the latter. The investigated cytokine profiles showed high convergence in both AD and PS patients, confirming the active inflammatory nature of these diseases.

MEDICINA-LITHUANIA (2022)

No Data Available